Scientific Sessions 2024  /  From Intervention to Prevention: Advances in Coronary and Valvular Heart Disease  /  Discussant: CLEAR SYNERGY

American Heart Association

  16
  0

Final ID:

Discussant: CLEAR SYNERGY

  • Bonaca, Marc  ( CPC Clinical Research , Aurora , Colorado , United States )
    • Author Disclosures:
    Marc Bonaca: DO have relevant financial relationships ; Research Funding (PI or named investigator):Dr. Bonaca is the Executive Director of CPC:Active (exists now) ; Research Funding (PI or named investigator):Dr. Bonaca is the Executive Director of CPC:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

From Intervention to Prevention: Advances in Coronary and Valvular Heart Disease

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
the CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine versus placebo and Spironolactone versus placebo in Patients with Myocardial Infarction. The results of the spironolactone factorial.

Jolly Sanjit

Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early after Surgical Bioprosthetic Valve Replacement: ENBALV trial

Izumi Chisato, Amano Masashi, Fukushima Satsuki, Yaku Hitoshi, Eishi Kiyoyuki, Sakaguchi Taichi, Minami Manabu, Yamamoto Haruko, Omae Katsuhiro

More abstracts from these authors:
Medical Therapy and Outcomes in Patients with Critical Limb Threatening Ischemia Randomized to an Everolimus Eluting Resorbable Scaffold or Angioplasty in the LIFE-BTK Randomized Trial

Bonaca Marc, Derubertis Brian, Varcoe Ramon, Parikh Sahil

Antithrombotic prophylaxis in patients with peripheral arterial disease

Bonaca Marc, Creager Mark

You have to be authorized to contact abstract author. Please, Login
Not Available